Epidemiology and clinical features of systemic vasculitis

Clinical and Experimental Nephrology

Volumn 17, Issue 5, 2013, Pages 607-610

  Scott, David G I ^a   Watts, Richard A ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

ANCA; EGPA; Epidemiology; GPA; MPA; Vasculitis

Indexed keywords

ALKALINE PHOSPHATASE; C REACTIVE PROTEIN; CARDIOLIPIN ANTIBODY; CRYOGLOBULIN; GAMMA GLUTAMYLTRANSFERASE; RHEUMATOID FACTOR;

AGE DISTRIBUTION; ALKALINE PHOSPHATASE BLOOD LEVEL; ANCA ASSOCIATED VASCULITIS; ANTIBODY SPECIFICITY; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; EOSINOPHILIC GRANULOMA; ERYTHROCYTE SEDIMENTATION RATE; ETHNICITY; EUROPE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENETIC ASSOCIATION; HUMAN; IMMUNOGLOBULIN A VASCULITIS; INCIDENCE; INDIA; LUNG FUNCTION TEST; LYMPHOCYTOPENIA; MEDICAL SOCIETY; MICROSCOPIC POLYANGIITIS; MUCOCUTANEOUS LYMPH NODE SYNDROME; NOMENCLATURE; PROTEIN BLOOD LEVEL; REVIEW; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS; WEGENER GRANULOMATOSIS;

AGE OF ONSET; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; SYSTEMIC VASCULITIS; TERMINOLOGY AS TOPIC;

EID: 84887255486     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-013-0830-8     Document Type: Review

References (14)

1. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013; 65(1):1-11.
2. Watts RA, Scott DGI. Epidemiology of vasculitis. In: Bridges L, Ball G, editors. Vasculitis. 3rd ed. Oxford: Oxford University Press; 2013 (in press).
3. Fries JF, Hunder GG, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis: summary. Arthritis Rheum. 1990;33:1135-6.
4. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994;37:187-92.
5. Scott DGI, Watts R. Classification and epidemiology of systemic vasculitis. Br J Rheumatol. 1994;33:897-9.
6. Mahr A, Guillevin L, Poissonnet M, Ayme S. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis Rheum. 2004;51:92-9.
7. Watts RA, Mooney J, Skinner J, Scott DGI, MacGregor AJ. The contrasting epidemiology of granulomatosis with polyangiitis (Wegener's granulomatosis) and microscopic polyangiitis. Rheumatology. 2012;51:926-31.
8. Watts RA, González-Gay M, Garcia-Porrua C, Lane S, Bentham G, Scott DGI. Geoepidemiology of systemic vasculitis. Ann Rheum Dis. 2001;60:170-2.
9. Fujimoto S, Watts RA, Kobayashi S, Suzuki K, Jayne DRW, Scott GDI, Hashimoto H, Nunoi H. Comparison of the epidemiology of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis between Japan and UK. Rheumatology. 2011;50:1916-20.
10. Watts RA, Scott DGI. ANCA vasculitis: to lump or split? Rheumatology. 2012;. doi: 10.1093/rheumatology/kes230.
11. Gatenby PA, Lucas RM, Engelson O, Ponsonby AL, Clements M. Anti-neutrophil cytoplasmic antibody associated vasculitis: could geographic patterns be explained by ambient ultraviolet radiation. Arthritis Rheum. 2009;61:1417-24.
12. Yashiro M, Muso E, Itoh-Ihara T, et al. Significantly high regional morbidity of MPO-ANCA related angiitis and/or nephritis with respiratory tract involvement after the 1995 great earthquake in Kobe (Japan). Am J Kidney Dis. 2000;35:889-95.
13. Lane SE, Watts RA, Bentham G, Innes NJ, Scott DG. Are environmental factors important in primary systemic vasculitis? A case control study. Arthritis Rheum. 2003;48:124-32.
14. Knight A, Sandin S, Askling J. Risks and relative risks of Wegener's granulomatosis among close relatives of patients with the disease. Arthritis Rheum. 2008;58:302-7.